Molecular subtype identification and prognosis stratification by a metabolism-related gene expression signature in colorectal cancer.
Molecular subtype identification and prognosis stratification by a metabolism-related gene expression signature in colorectal cancer.
复制标题
通过结直肠癌代谢相关基因表达特征进行分子亚型鉴定和预后分层
DOI:
10.1186/s12967-021-02952-w
复制
发表时间:
2021-06-30
影响因子:
7.4
通讯作者:
Li L
中科院分区:
文献类型:
--
作者:
Lin D;Fan W;Zhang R;Zhao E;Li P;Zhou W;Peng J;Li L
Metabolic reprograming have been associated with cancer occurrence and progression within the tumor immune microenvironment. However, the prognostic potential of metabolism-related genes in colorectal cancer (CRC) has not been comprehensively studied. Here, we investigated metabolic transcript-related CRC subtypes and relevant immune landscapes, and developed a metabolic risk score (MRS) for survival prediction. Metabolism-related genes were collected from the Molecular Signatures Database and metabolic subtypes were identified using an unsupervised clustering algorithm based on the expression profiles of survival-related metabolic genes in GSE39582. The ssGSEA and ESTIMATE methods were applied to estimate the immune infiltration among subtypes. The MRS model was developed using LASSO Cox regression in the GSE39582 dataset and independently validated in the TCGA CRC and GSE17537 datasets. We identified two metabolism-related subtypes (cluster-A and cluster-B) of CRC based on the expression profiles of 539 survival-related metabolic genes with distinct immune profiles and notably different prognoses. The cluster-B subtype had a shorter OS and RFS than the cluster-A subtype. Eighteen metabolism-related genes that were mostly involved in lipid metabolism pathways were used to build the MRS in GSE39582. Patients with higher MRS had worse prognosis than those with lower MRS (HR 3.45, P < 0.001). The prognostic role of MRS was validated in the TCGA CRC (HR 2.12, P = 0.00017) and GSE17537 datasets (HR 2.67, P = 0.039). Time-dependent receiver operating characteristic curve and stratified analyses revealed the robust predictive ability of the MRS in each dataset. Multivariate Cox regression analysis indicted that the MRS could predict OS independent of TNM stage and age. Our study provides novel insight into metabolic heterogeneity and its relationship with immune landscape in CRC. The MRS was identified as a robust prognostic marker and may facilitate individualized therapy for CRC patients. The online version contains supplementary material available at 10.1186/s12967-021-02952-w.
登录
查看更多内容
影响因子:
16.6
作者:
Koyama S;Akbay EA;Li YY;Herter-Sprie GS;Buczkowski KA;Richards WG;Gandhi L;Redig AJ;Rodig SJ;Asahina H;Jones RE;Kulkarni MM;Kuraguchi M;Palakurthi S;Fecci PE;Johnson BE;Janne PA;Engelman JA;Gangadharan SP;Costa DB;Freeman GJ;Bueno R;Hodi FS;Dranoff G;Wong KK;Hammerman PS
通讯作者:
Hammerman PS
影响因子:
5.3
作者:
Meng X;Feng C;Fang E;Feng J;Zhao X
通讯作者:
Zhao X
影响因子:
37.3
作者:
Chen, Yunzhao;Wang, Dandan;Li, Feng
通讯作者:
Li, Feng
影响因子:
3.7
作者:
Parry M;Rose-Zerilli MJ;Gibson J;Ennis S;Walewska R;Forster J;Parker H;Davis Z;Gardiner A;Collins A;Oscier DG;Strefford JC
通讯作者:
Strefford JC
影响因子:
2
作者:
Kang, Le;Chen, Weijie;Petrick, Nicholas A.;Gallas, Brandon D.
通讯作者:
Gallas, Brandon D.